Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05821972

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine to Induce Preoperative Sedation and Attenuate Emergence Agitation in Children Undergoing Cleft Palate Repair Surgeries

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
12 Months – 48 Months
Healthy volunteers
Not accepted

Summary

To compare the efficacy of the pre-operative nebulization of a combination of dexmedetomidine and ketamine versus nebulization of dexmedetomidine alone for sedation and prevention of emergence delirium in children undergoing cleft palate repair surgeries.

Detailed description

Cleft palate is a common congenital anomaly. The American cleft palate-craniofacial Association recommends that primary cleft palate repair should be ideally performed between 12-18 months after birth. The pre-operative period is quite distressing for children due to parental separation, application of face mask for induction of anaesthesia, fear of needles and unfamiliar faces. Pre-operative Anxiety is associated with adverse outcomes via elevation of stress markers, promoting fluctuations in hemodynamic, and negatively impacting postoperative recovery. There is a growing interest in the use of dexmedetomidine, a highly selective alpha-2 adrenergic agonist, for paediatric premedication. Ketamine may attenuate dexmedetomidine-induced bradycardia and hypotension and accelerate the onset of sedation with no respiratory depression.

Conditions

Interventions

TypeNameDescription
DRUGNebulization of dexmedetomidine and ketaminePre-operative nebulization of dexmedetomidine and ketamine
DRUGNebulization of dexmedetomidinePre-operative nebulization of dexmedetomidine

Timeline

Start date
2024-04-10
Primary completion
2025-10-20
Completion
2025-10-30
First posted
2023-04-20
Last updated
2025-10-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05821972. Inclusion in this directory is not an endorsement.

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate (NCT05821972) · Clinical Trials Directory